Common γ chain cytokines: Dissidence in the details

Immunology Letters

Volumn 108, Issue 2, 2007, Pages 113-120

  Alves, Nuno L ^a   Arosa, Fernando A ^b   van Lier, René A W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

c cytokines; CD8 T cells; Homeostasis

Indexed keywords

CYTOKINE; GAMMA CYTOKINE; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 7; UNCLASSIFIED DRUG;

CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; HOMEOSTASIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOPOIESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; HOMEOSTASIS; HUMANS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; INTERLEUKINS; LYMPHOCYTE ACTIVATION;

EID: 33846650265     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2006.11.006     Document Type: Review

References (110)

1. Leonard W.J., and Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 5 (2005) 688-698
2. Cao X., Shores E.W., Hu-Li J., Anver M.R., Kelsall B.L., Russell S.M., et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2 (1995) 223-238
3. DiSanto J.P., Muller W., Guy-Grand D., Fischer A., and Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA 92 (1995) 377-381
4. von Freeden-Jeffry U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., and Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 181 (1995) 1519-1526
5. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 180 (1994) 1955-1960
6. + T cell development. J Exp Med 200 (2004) 159-168
7. Ziegler S.F., and Liu Y.J. Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 7 (2006) 709-714
8. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191 (2000) 771-780
9. Lodolce J.P., Boone D.L., Chai S., Swain R.E., Dassopoulos T., Trettin S., et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9 (1998) 669-676
10. Schluns K.S., Nowak E.C., Cabrera-Hernandez A., Puddington L., Lefrancois L., and Aguila H.L. Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor α expression. Proc Natl Acad Sci USA 101 (2004) 5616-5621
11. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., and Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75 (1993) 253-261
12. Willerford D.M., Chen J., Ferry J.A., Davidson L., Ma A., and Alt F.W. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3 (1995) 521-530
13. Malek T.R., Yu A., Vincek V., Scibelli P., and Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17 (2002) 167-178
14. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 (2005) 1142-1151
15. Ozaki K., Spolski R., Feng C.G., Qi C.F., Cheng J., Sher A., et al. A critical role for IL-21 in regulating immunoglobulin production. Science 298 (2002) 1630-1634
16. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., and Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89 (1997) 1033-1041
17. Kondo M., Akashi K., Domen J., Sugamura K., and Weissman I.L. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common γ chain-deficient mice. Immunity 7 (1997) 155-162
18. -/- mice. Cell 89 (1997) 1011-1019
19. Pellegrini M., Bouillet P., Robati M., Belz G.T., Davey G.M., and Strasser A. Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice. J Exp Med 200 (2004) 1189-1195
20. Oliver P.M., Wang M., Zhu Y., White J., Kappler J., and Marrack P. Loss of Bim allows precursor B cell survival but not precursor B cell differentiation in the absence of interleukin 7. J Exp Med 200 (2004) 1179-1187
21. Dias S., Silva Jr. H., Cumano A., and Vieira P. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. J Exp Med 201 (2005) 971-979
22. Vosshenrich C.A., Ranson T., Samson S.I., Corcuff E., Colucci F., Rosmaraki E.E., et al. Roles for common cytokine receptor γ-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 174 (2005) 1213-1221
23. -/- mice: roles for both IL-2 and IL-15 in CD8αα EL development. J Immunol 163 (1999) 5906-5912
24. + T cells. Immunity 25 (2006) 79-91
25. + T cells. Proc Natl Acad Sci USA 103 (2006) 12075-12080
26. c-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol Rev 202 (2004) 67-83
27. Giliani S., Mori L., de Saint B.G., Le D.F., Rodriguez-Perez C., Forino C., et al. Interleukin-7 receptor α (IL-7Rα) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol Rev 203 (2005) 110-126
28. Tan J.T., Dudl E., LeRoy E., Murray R., Sprent J., Weinberg K.I., et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 98 (2001) 8732-8737
29. + cells. J Exp Med 195 (2002) 1523-1532
30. + T cells. J Exp Med 195 (2002) 1533-1539
31. Tanchot C., Lemonnier F.A., Perarnau B., Freitas A.A., and Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 276 (1997) 2057-2062
32. Schluns K.S., Kieper W.C., Jameson S.C., and Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 1 (2000) 426-432
33. + T cells. J Exp Med 195 (2002) 1515-1522
34. + T cells. J Immunol 170 (2003) 5018-5026
35. + T cells. J Exp Med 196 (2002) 935-946
36. Becker T.C., Wherry E.J., Boone D., Murali-Krishna K., Antia R., Ma A., et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 195 (2002) 1541-1548
37. + T cells in vivo by IL-15. Immunity 8 (1998) 591-599
38. + T cell survival but not for antigen proliferation. Nat Immunol 1 (2000) 54-58
39. Li J., Huston G., and Swain S.L. IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 198 (2003) 1807-1815
40. Kondrack R.M., Harbertson J., Tan J.T., McBreen M.E., Surh C.D., and Bradley L.M. Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med 198 (2003) 1797-1806
41. Seddon B., Tomlinson P., and Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 4 (2003) 680-686
42. + T cells. J Exp Med 194 (2001) 1711-1719
43. + memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 101 (2003) 4260-4266
44. Cookson S., and Reen D. IL-15 drives neonatal T cells to acquire CD56 and become activated effector cells. Blood 102 (2003) 2195-2197
45. Schonland S.O., Zimmer J.K., Lopez-Benitez C.M., Widmann T., Ramin K.D., Goronzy J.J., et al. Homeostatic control of T-cell generation in neonates. Blood 102 (2003) 1428-1434
46. + T cells in vitro. Blood 102 (2003) 2541-2546
47. + T cells. J Immunol 175 (2005) 755-762
48. O'Neill R.M., Hassan J., and Reen D.J. IL-7-regulated homeostatic maintenance of recent thymic emigrants in association with caspase-mediated cell proliferation and apoptotic cell death. J Immunol 170 (2003) 4524-4531
49. Wallace D.L., Berard M., Soares M.V., Oldham J., Cook J.E., Akbar A.N., et al. Prolonged exposure of naive CD8 T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. Immunology 19 (2006) 243-253
50. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., Gross J.A., et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408 (2000) 57-63
51. + T cells. Blood 101 (2003) 1024-1029
52. + T cells in vitro. J Immunol 174 (2005) 4019-4024
53. + effector-memory T cells. Int Immunol 15 (2003) 49-58
54. Kassiotis G., Zamoyska R., and Stockinger B. Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J Exp Med 197 (2003) 1007-1016
55. + T cell survival controlled by clonal abundance. Science 312 (2006) 114-116
56. Tough D.F., and Sprent J. Turnover of naive- and memory-phenotype T cells. J Exp Med 179 (1994) 1127-1135
57. Michie C.A., McLean A., Alcock C., and Beverley P.C. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 360 (1992) 264-265
58. Park J.H., Yu Q., Erman B., Appelbaum J.S., Montoya-Durango D., Grimes H.L., et al. Suppression of IL7Rα transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21 (2004) 289-302
59. Schluns K.S., and Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 3 (2003) 269-279
60. + memory T cells. Nature 441 (2006) 890-893
61. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., and Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4 (2003) 1191-1198
62. Wherry E.J., Barber D.L., Kaech S.M., Blattman J.N., and Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc Nat Acad Sci USA 101 (2004) 16004-16009
63. + T cells. Blood 106 (2005) 2091-2098
64. + memory T cell subsets. Proc Natl Acad Sci USA 101 (2004) 5610-5615
65. +T cells: diversity specialists. Immunol Rev 211 (2006) 225-235
66. Xue H.H., Kovanen P.E., Pise-Masison C.A., Berg M., Radovich M.F., Brady J.N., et al. IL-2 negatively regulates IL-7 receptor α chain expression in activated T lymphocytes. Proc Natl Acad Sci USA 99 (2002) 13759-13764
67. Buentke E., Mathiot A., Tolaini M., Di S.J., Zamoyska R., and Seddon B. Do CD8 effector cells need IL-7R expression to become resting memory cells?. Blood 108 (2006) 1949-1956
68. Klonowski K.D., Williams K.J., Marzo A.L., and Lefrancois L. Cutting edge: IL-7-independent regulation of IL-7 receptor α expression and memory CD8 T cell development. J Immunol 177 (2006) 4247-4251
69. Schluns K.S., Williams K., Ma A., Zheng X.X., and Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 168 (2002) 4827-4831
70. + T cell contraction during primary infection. J Immunol 176 (2006) 507-515
71. + T cell expansion and function. J Exp Med 201 (2005) 139-148
72. + CTL after reinfection. J Immunol 174 (2005) 3590-3597
73. + T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J Immunol 173 (2004) 900-909
74. + memory T cells. Proc Natl Acad Sci USA 99 (2002) 6192-6197
75. + T cells. Blood 100 (2002) 3253-3260
76. Roberts A.I., Lee L., Schwarz E., Groh V., Spies T., Ebert E.C., et al. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol 167 (2001) 5527-5530
77. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21 (2004) 357-366
78. Parrish-Novak J., Foster D.C., Holly R.D., and Clegg C.H. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J Leukoc Biol 72 (2002) 856-863
79. Wu Z., Kim H.P., Xue H.H., Liu H., Zhao K., and Leonard W.J. Interleukin-21 receptor gene induction in human T cells is mediated by T-cell receptor-induced Sp1 activity. Mol Cell Biol 25 (2005) 9741-9752
80. Ma H.L., Whitters M.J., Konz R.F., Senices M., Young D.A., Grusby M.J., et al. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perform but are independent of IFN-γ. J Immunol 171 (2003) 608-615
81. Takaki R., Hayakawa Y., Nelson A., Sivakumar P.V., Hughes S., Smyth M.J., et al. IL-21 enhances tumor rejection through a NKG2D-dependent mechanism. J Immunol 175 (2005) 2167-2173
82. Kasaian M.T., Whitters M.J., Carter L.L., Lowe L.D., Jussif J.M., Deng B., et al. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16 (2002) 559-569
83. Strengell M., Matikainen S., Siren J., Lehtonen A., Foster D., Julkunen I., et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells. J Immunol 170 (2003) 5464-5469
84. Li Y., Bleakley M., and Yee C. IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response. J Immunol 175 (2005) 2261-2269
85. + T cells. J Immunol 176 (2006) 1490-1497
86. + T cell immune responses. Blood 107 (2006) 2855-2862
87. + T cell memory. Proc Natl Acad Sci USA 101 (2004) 9357-9362
88. Fehniger T.A., and Caligiuri M.A. Interleukin 15: biology and relevance to human disease. Blood 97 (2001) 14-32
89. Jiang Q., Li W.Q., Aiello F.B., Mazzucchelli R., Asefa B., Khaled A.R., et al. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 16 (2005) 513-533
90. + T-cell response. Nat Rev Immunol 4 (2004) 595-602
91. Bolotin E., Annett G., Parkman R., and Weinberg K. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant 23 (1999) 783-788
92. Napolitano L.A., Grant R.M., Deeks S.G., Schmidt D., De Rosa S.C., Herzenberg L.A., et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 7 (2001) 73-79
93. Dubois S., Mariner J., Waldmann T.A., and Tagaya Y. IL-15Rα recycles and presents IL-15 In trans to neighboring cells. Immunity 17 (2002) 537-547
94. Lodolce J.P., Burkett P.R., Boone D.L., Chien M., and Ma A. T cell-independent interleukin 15Rα signals are required for bystander proliferation. J Exp Med 194 (2001) 1187-1194
95. + bone marrow-derived cells. Blood 103 (2004) 988-994
96. + T cells is dispensable for T cell memory. Proc Natl Acad Sci USA 100 (2003) 4724-4729
97. + T cell homeostasis. J Exp Med 200 (2004) 825-834
98. Sandau M.M., Schluns K.S., Lefrancois L., and Jameson S.C. Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15Rα by the same cells. J Immunol 173 (2004) 6537-6541
99. Boyman O., Kovar M., Rubinstein M.P., Surh C.D., and Sprent J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311 (2006) 1924-1927
100. Williamson P., Merida I., and Gaulton G. Protein and lipid kinase activation cascades in interleukin-2 receptor signalling. Semin Immunol 5 (1993) 337-344
101. Dubois S., Shou W., Haneline L.S., Fleischer S., Waldmann T.A., and Muller J.R. Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2- versus IL-15-mediated proliferation of T cells. Proc Natl Acad Sci USA 100 (2003) 14169-14174
102. + T cell differentiation. Immunity 18 (2003) 475-487
103. Davey G.M., Starr R., Cornish A.L., Burghardt J.T., Alexander W.S., Carbone F.R., et al. SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential. J Exp Med 202 (2005) 1099-1108
104. Alpdogan O., and van den Brink M.R. IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol 26 (2005) 56-64
105. + T-regulatory cells. J Immunother 29 (2006) 313-319
106. Waldmann T.A. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol 6 (2006) 595-601
107. Oh S., Berzofsky J.A., Burke D.S., Waldmann T.A., and Perera L.P. Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc Natl Acad Sci USA 100 (2003) 3392-3397
108. Kutzler M.A., Robinson T.M., Chattergoon M.A., Choo D.K., Choo A.Y., Choe P.Y., et al. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol 175 (2005) 112-123
109. + memory cell pool. J Clin Invest 115 (2005) 1177-1187
110. Villinger F., Miller R., Mori K., Mayne A.E., Bostik P., Sundstrom J.B., et al. IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques. Vaccine 22 (2004) 3510-3521